Hakan Keles

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Low Density Lipoprotein

Endoplasmic Reticulum

Pulmonary Hypertension

Fluorescence Imaging

Top Venues

ACS pharmacology & translational science

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Rutkowska-Klute, H Christian Eberl, Thilo Werner, Marco L Hennrich, Daniel C Sevin, Massimo Petretich, James P Reddington, Shirin Pocha, Stephan Gade, Amalia Martinez-Segura, Dmytro Dvornikov, Joel Karpiak, Gavain M A Sweetman, Christian Fufezan, Birgit Duempelfeld, Florian Braun, Christopher A Schofield, Hakan Keles, David Alvarado, Zhuo Wang, Keith H Jansson, Maria Fälth-Savitski, Edward Curry, Katja Remlinger, Euan A Stronach, Bin Feng, Geeta Sharma, Kevin Coleman, Paola Grandi, Marcus Bantscheff, Giovanna Bergamini
Synergistic effects of PARP inhibition and cholesterol biosynthesis pathway modulation. Cancer research communications (2024)
Hakan Keles, Christopher A Schofield, Helena Rannikmae, Erin Elizabeth Edwards, Lisa Mohamet
A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Subnuclear γH2AX Spots in Patient Derived Ovarian Cancer Organoids. ACS pharmacology & translational science 6 (1) (2022)
Martha Triantafilou, Joshi Ramanjulu, Lee M Booty, Gisela Jimenez-Duran, Hakan Keles, Ken A Saunders, Neysa Nevins, Emma Koppe, Louise K Modis, G Scott Pesiridis, John Bertin, Kathy Triantafilou
Human rhinovirus promotes STING trafficking to replication organelles to promote viral replication. Nature communications 13 (1) (2022)
Hakan Keles, Christopher A Schofield, Helena Rannikmae, Erin Elizabeth Edwards, Lisa Mohamet
A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Subnuclear γH2AX Spots in Patient Derived Ovarian Cancer Organoids. ACS pharmacology & translational science 6 (1) (2022)